Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2026-02-24 00:00:00 ET · period of report 2026-02-23 · accession 0001628280-26-011211 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-24 | 2026-02-23 | MDGL | Levy Richard S | Dir | M - OptEx | $7.36 | +2,500 | 27.7K | +10% | +$18.4K |
| D | 2026-02-24 | 2026-02-23 | MDGL | Levy Richard S | Dir | M - OptEx | $0.00 | -2,500 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-23 | M | A | 2,500 | $7.36 | 27,697 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-02-23 | M | D | 2,500 | $0.00 | 0 | D | $7.36 · — to 2026-08-11 | 2,500 Common Stock | (F1) The shares underlying this option are fully vested and exercisable. |